Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
524.00    4.00 (0.77%)
Bid:
524.00
Ask:
528.00
Spread: 4.00 (0.763%)
Market Cap: £867.04m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Trading Update

29 Jan 2016 07:00

RNS Number : 3778N
Oakley Capital Investments Limited
29 January 2016
 

29 January 2016

 

 

Oakley Capital Investments Limited ("OCIL" or the "Company")

 

 

Trading Update for the 12 months ended 31 December 2015

 

 

· NAV per share (unaudited) expected to be in the range of £1.98 - £2.00 representing an increase of approximately 9% on June 2015

· Aggregate increase in fair value across both Fund portfolios of 31% (since June 2015)

· Oakley Funds have deployed €148m during 2015

· £77m invested by the Company in the period through its continuing co-investment programme facilitated by the £130m Placing in March 2015

· Successful exits returned €63m to the Company. Fund IRR generated of 64%

· Commitment of €250m to Fund III

 

Oakley Capital Investments Limited (AIM: OCL, "OCIL"), the AIM-listed company established to provide investors with access to the investment strategy being pursued by Oakley Capital Private Equity L.P. ("Fund I") and its successor fund, Oakley Capital Private Equity II ("Fund II") (together the "Funds"), today announces a trading update for the 12 months ended 31 December 2015.

 

The Company, through its investment in Fund I, has an indirect interest in each of Fund I's portfolio companies representing 65.5% of Fund I's total commitments; and through its investment in Fund II, an indirect interest in each of Fund II's portfolio companies representing 38.1% of Fund II's total commitments.

 

Oakley Capital Limited, OCIL's Investment Adviser, estimates that the Company's net asset value, which is subject to the completion of the 31 December 2015 audit of the Funds, and the Company, will be in the range of £378 million to £382 million, equating to a net asset value ("NAV") per share of between £1.98 to £2.00 (30 June 2015: £1.82). The overall increase in fair value across both Fund portfolios on a like-for-like basis is 31%, driven by strong portfolio company performances in Fund II. As at 31st December 2015, we expect the gross realised and unrealised returns to be 37% and 53% IRR and 2.2x and 1.6x money multiple for Fund I and Fund II's portfolio respectively. The OCIL net asset value is made up of cash, the investment in the Funds, co-investments, short-term bridging finance for the Funds and loans provided to a number of the portfolio companies.

 

Peter Dubens, Director, commented:

 

"The underlying performance of the Funds' portfolio companies has been strong over the period, reflected in the 31% growth in the fair value of their investment portfolios over the last six months, and driven by substantial EBITDA growth. The Funds had two exits in the period generating a combined gross IRR of 64%, providing good returns for our Investors.

 

We continue to see a dynamic pipeline of attractive investment opportunities which should enable the Funds and the Company to maintain their deployment record."

 

Key Highlights

· Fund I

o Fund I is fully invested and at the year end has just three portfolio companies remaining.

o The performance of this 2007 vintage fund has been extremely strong with a realised IRR of 46% and gross money multiple of 3.5x.

o In June 2015, Fund I disposed its controlling stake in Verivox to ProSieben, generating a gross money multiple of 14.5x and an IRR of 68%. Total proceeds of €56.3m were distributed to Fund investors, including €36.8m to the Company.

· Fund II

o Fund II is now 73% invested across nine portfolio companies.

o The portfolio of Fund II, which closed in December 2014 and hence is still relatively young, has seen an increase in its value to an IRR of 53% and gross money multiple of 1.6x (realised and unrealised).

o Fund II has made a total of nine investments, of which one has already been realised. The following new commitments were made during 2015:

- Damovo II Sarl, a provider of enterprise information communication technology (ICT) services and solutions, which will seek to replicate the success of Daisy through a European roll-up strategy led by founder of Daisy, Matthew Riley.

- Parship GmbH, one of Europe's earliest online dating businesses and the leading online matchmaker in Germany. Parship has a strong record of growth, which is continuing. Furthermore, shortly after the acquisition, the second player in the market, Elite Partner, was also acquired in an off market transaction which consolidates Parship's market position.

- Daisy Group Holding Limited ("Daisy") is the leading UK supplier of unified business communications and IT services and solutions. The Company is familiar with Daisy, having received considerable value when Fund I exited its 13.6% holding in Daisy in late 2014. The acquisition of Phoenix by Daisy provided an opportunity for Oakley to participate in its next strategic phase as a minority investor alongside the founder and chairman, Matthew Riley.

- Verivox, a market leader in Germany for online price comparison. Fund II had the opportunity to acquire a minority stake alongside ProSieben when Fund I exited, and therefore benefit from the synergies that will be achieved as well as the ongoing growth in this market. The Fund has a put option after five years.

Fund II has also benefitted from an exit and refinancing to return proceeds to fund investors:

- intergenia, the Fund's first investment, was sold to HEG Co. GmbH ("Host Europe"), the market leader, representing a gross money multiple of 1.4x and IRR of 47% for Fund II in under 12 months. Proceeds of €20.4m were distributed to the Company.

- facile, the leading Italian price comparison website acquired in 2013, was able to refinance its debt during the summer thanks to strong trading and cash generation, returning 20% of invested capital to the Fund, including €5.2m to OCIL.

· Co-investments:

During the year, the Company made co-investments and loans alongside the funds of £77million providing an efficient means of utilising the assets of OCIL in a prudent way. For the period since inception the IRR on OCIL's loans and cash has been in excess of 5% per annum.

· Commitment to Fund III

Following the new investments over the past 12 months, Fund II is now almost fully invested so OCIL has agreed to make, in line with its investing policy, a commitment of €250 million to Oakley Capital III, a successor fund.

Fund III will execute the same proven strategy as Oakley Capital Private Equity's previous Funds I and II.

· Capital Markets Day

OCIL will host a Capital Markets Day for institutional investors and analysts on 25th April 2016. A series of presentations will be given by the senior management team of the Company's Investment Adviser, Oakley Capital Limited, and by CEOs of several of the Limited Partnership's portfolio companies. No new material information will be disclosed.

 

- ends -

 

 

For further information please contact:

 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens

 

Liberum Capital Limited (Broker & Nominated Adviser)

+44 20 3100 2000

Steve Pearce / Tom Fyson

 

FTI Consulting LLP

+44 20 3727 1000

Edward Bridges / Emily Desmier

 

 

About Oakley Capital Investments Limited ("OCL")

Oakley Capital Investments Limited is a Bermudan based company listed on AIM. OCL seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P. and Oakley Capital Private Equity II and through co-investment opportunities.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEEEFAFMSEEF
Date   Source Headline
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
17th May 20238:04 amRNSOakley Capital extends IU Group partnership
10th May 20237:00 amRNSSale and Reinvestment in IU Group
26th Apr 20237:00 amRNSTrading update for the 3 months ended 31 Mar 2023
18th Apr 20237:00 amRNSOakley partners with schools group Thomas's
4th Apr 20231:13 pmRNSInitiation from QuotedData
31st Mar 20238:00 amEQSHardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation
16th Mar 20237:00 amRNSDirector Dealing
15th Mar 20237:15 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
9th Mar 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
27th Feb 20237:00 amRNSNotice of Results and Investor Presentation
25th Jan 20237:00 amRNSTrading update for the year ended 31 December 2022
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20232:15 pmEQSHardman & Co Q&A on Oakley Capital Investments Ltd (OCI): High-growth drivers in 2023
15th Dec 20227:00 amRNSOCI commits EUR 30m to Oakley PROfounders III
29th Nov 20227:30 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): Evolution of the high-growth drivers in 2023
10th Nov 20224:17 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.